The FLUOX-PMS Trial: Underestimating the Challenge in Progressive Multiple Sclerosis Trials

Multiple Sclerosis - United States
doi 10.1177/1352458519856985
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

Progressive Multiple Sclerosis: The Treatment Gap

Nature
Multidisciplinary
2012English

Sample Sizes for Brain Atrophy Outcomes in Trials for Secondary Progressive Multiple Sclerosis

Neurology
Neurology
2008English

Exercise Training in Progressive Multiple Sclerosis

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2016English

Restoring Function in Progressive Multiple Sclerosis

The Lancet Neurology
Neurology
2019English

Ocrelizumab in the Treatment of Primary-Progressive Multiple Sclerosis

Medical Council
2018English

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle

Frontiers in Neurology
Neurology
2017English

Costs Associated With the Impact of Progressive Multiple Sclerosis: Insights From a Three Year Clinical Trial (The Cupid Trial)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Trials of Antivirals in the Treatment of Multiple Sclerosis

Acta Neurologica Scandinavica
MedicineNeurology
2017English

New Age for Progressive Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy